What is Amifampridine phosphate (3,4 Diaminopyridine)?

Category: Prescription Drugs

false

Amifampridine phosphate (3,4-diaminopyridine or 3,4-DAP) ia an orphan drug used in the treatment of Lambert Eaton Myasthenic Syndrome. It works by blocking potassium channel efflux in nerve terminals so that action potential duration is increased.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with Amifampridine phosphate (3,4 Diaminopyridine)

Side effect Patients
Loss of sensation in fingers of right hand 1

Why patients stopped taking Amifampridine phosphate (3,4 Diaminopyridine)

Multiple reasons could be selected

Reason Patients
Side effects too severe 1
See 1 patient who's stopped taking Amifampridine phosphate (3,4 Diaminopyridine)

Duration

Stopped taking Amifampridine phosphate (3,4 Diaminopyridine)

Duration Patients
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Last updated:
There are no evaluations for Amifampridine phosphate (3,4 Diaminopyridine).